GSK picks ex

© Reuters. FILE PHOTO: Dave Lewis,Aihua Forex official website download Tesco CEO, speaks at the the British Chamber of Commerce annual conference in London, Britain, March 28, 2019. REUTERS/Peter Nicholls

By Anirudh Saligrama

(Reuters) -British drugmaker GlaxoSmithKline (NYSE:GSK) Plc has picked Dave Lewis, former chief executive of Tesco (OTC:TSCDY) Plc, to chair its consumer healthcare unit, which is due to be spun off next year, a source familiar with the matter said on Sunday.

Confirmation of Lewis's appointment as non-executive chairman of the arm that owns brands including Sensodyne toothpaste could come as soon as Monday, the source told Reuters.

Lewis left Tesco in September after six years as CEO.

GSK owns 68% of the unit and Pfizer Inc (NYSE:PFE) the remainder. In July, GSK said its current head, Brian McNamara, would take over as CEO once it was spun off.

GSK said in October it was on track to spin the unit off next year at a valuation of upwards of 40 billion pounds ($53 billion).

($1 = 0.7551 pounds)

Statement: The content of this article does not represent the views of FTI website. The content is for reference only and does not constitute investment suggestions. Investment is risky, so you should be careful in your choice! If it involves content, copyright and other issues, please contact us and we will make adjustments at the first time!